Skip to main content
Premium Trial:

Request an Annual Quote

Tecan, Covaris Enter Co-marketing Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tecan announced today that it has inked a co-marketing deal with Covaris to offer Covaris' Adaptive Focused Acoustics systems with Tecan's Freedom EVO liquid handling instruments.

The firms said that the technologies have already been integrated for several applications and will be available to customers worldwide for sample preparation, compound management, and next-generation sequencing.

"AFA is gaining widespread acceptance in the compound management community for rapid thawing, mixing and dissolution of samples, as well as for DNA shearing in the exciting area of next-generation sequencing," Kevin Moore, Tecan’s director of market and application management for BioPharma, said in a statement.

Financial and other terms of the alliance were not disclosed.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.